Aveanna Healthcare Holdings 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Aveanna Healthcare Holdings reported 3rd quarter 2026 revenue of $695.5 million, up 11.8% over the prior year period, and adjusted EBITDA of $100.1 million, up 25%.
- Revenue grew year over year in all 3 operating divisions: Private Duty Services increased 11.6% to approximately $574 million, Home Health and Hospice increased 15.6% to approximately $72.1 million, and Medical Solutions increased 9.1% to $49.2 million.
- Private Duty Services delivered approximately 13 million hours of care, up 10.2%, with revenue per hour of $44.09, up 1.4%; gross margin was $166 million, or 28.9%.
- Home Health and Hospice reported 11,600 admissions, up 19.6%, and 16,000 episodes of care, up 24%; 80% of the mix was episodic, Medicare revenue per episode was $3,199, and gross margin was 53.3%.
- Medical Solutions served approximately 98,000 unique patients, up 7.7%, with revenue per UPS of approximately $502, up 1.4%; gross margin was approximately $22.3 million, or 45.2%.
- Consolidated gross margin was $226.8 million, or 32.6%. Year-to-date cash generated by operating activities was $157.5 million and free cash flow was positive $141.2 million.
- At quarter end, liquidity was $492 million, including $198 million of cash on hand, $69 million of availability under the securitization facility, and $226 million of availability on an undrawn revolver; outstanding letters of credit were $24.4 million.
- Aveanna had approximately $1.52 billion of variable rate debt at quarter end, with $1.4 billion hedged with interest rate caps. After quarter end, it executed an additional $880 million cap effective upon expiration of existing caps in February 2027, with a 5.25% strike rate through December 2029.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good morning, and welcome to Aveanna Healthcare Holdings Third Quarter 2026 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this time, I'd like to turn the call over to Debbie Stewart, Aveanna's Chief Accounting Officer.
Please go ahead. Good morning, and welcome to Aveanna's Third Quarter 2026 Earnings Call.
I am Debbie Stewart, the company's Chief Accounting Officer. With me today is Jeff Shaner, our Chief Executive Officer, and Matt Buckhalter, our Chief Financial Officer. During this call, we will make forward-looking statements. Risk factors that may impact those statements and could cause actual future results to differ materially from currently projected results are described in this morning's press release and the reports we file with the SEC. The company does not undertake any duty to update such forward-looking statements. Additionally, during today's call, we will discuss certain non-GAAP measures, which we believe can be useful in evaluating our performance. The presentation of this additional information should not be considered in isolation or as a substitute for results prepared in accordance with GAAP.
A reconciliation of these measures can be found in this morning's press release, which is posted on our website, aveanna.com, and in our most recent quarterly report on Form 10-Q when filed. With that, I will turn the call over to Aveanna's Chief Executive Officer, Jeff Shaner.
Jeff? Thank you, Debbie. Good morning, and thank you for joining us today.
We appreciate each of you investing your time this morning to better understand our Q3 results and how we are finishing full year 2026 with solid momentum. My initial comments will briefly highlight our third quarter results, along with the steps we are taking to address the labor markets and our ongoing efforts with government and preferred payers to create additional capacity. I will then provide updates on the Family First integration, how we are progressing with our 2026 strategic initiatives, our enhanced guidance, and reconfirm our long-term growth outlook before turning the call over to Matt. Let's move to highlights for the third quarter. Revenue for the third quarter was $695.5 million, representing an 11.8% increase over the prior year period.
Third quarter adjusted EBITDA was $100.1 million, representing a 25% increase over the prior year period, primarily due to the improved rate and volume environment and continued operational efficiencies. As we have previously discussed, the labor environment represented the primary challenge that we needed to address to see Aveanna resume the growth trajectory that we believed our company could achieve. It is important to note that our industry does not have a demand problem. The demand for home and community-based care continues to be burgeoning, with both state and federal governments and managed care organizations asking for solutions that create more capacity while reducing the total cost of care. Our Q3 results highlight that we continue to align our objectives with those of our preferred payers and government partners.
By focusing our clinical capacity on our preferred payers, we achieved solid year-over-year growth in all three of our operating segments. We also experienced improvement in our caregiver hiring and retention trends by aligning our efforts with those payers willing to engage with us on enhanced reimbursement rates and value-based agreements. While we continue to operate in a challenging environment, our preferred payer strategy supports our ability to achieve accelerated growth rates in all three of our business segments. Since our second quarter earnings call, I am pleased with the continued progress we have made on several of our rate improvement initiatives with both government and preferred payer partners, as well as continued signs of improvement in the caregiver labor markets. Specifically, as it relates to our Private Duty Services business, our 2026 government affairs strategy was twofold.
First, to enhance our advocacy presence with both federal and state legislatures, and second, to achieve mid-single-digit state rate enhancements. As of Q3, we have achieved eight state rate enhancements year to date and have shifted our focus to the 2027 legislative agenda. Our messaging of lowering the total cost of care and keeping our medically fragile patients in the comfort of their home continues to resonate well with our state government partners. As we communicated in Q2, after four years of dedicated advocacy and focus on the state of California, we are expecting a significant investment in PDN rates effective January 1st, 2027. We have engaged extensively with the Department of Health Care Services, known as DHCS, on the adjudication of this rate investment in California.
DHCS has validated that the 2027 California budget includes a hard dollar investment for PDN rates of approximately $30 million, with the understanding that CMS will match it with their 50% FMAP matching, or an additional $30 million, for a total PDN rate investment of $60 million. DHCS believes this $60 million investment is a supplemental payment for the 2027 budget period of January 1st, 2027, through June 30th of 2027. The department has communicated that it will most likely apply this supplemental rate increase in addition to the PDN base rates for effectively all PDN patients covered by Medi-Cal. We are working with Governor Newsom and Governor-elect Becerra to ensure the supplemental payment continues to be included in the California budget as a permanent rate increase to the PDN rate structure.
We have every intention of passing material wage improvements onto our caregivers in concert with the permanent rate enhancement. We will continue to communicate and advocate with the Governor's office, California legislature, and the Department of Health Care Services until a permanent rate and wage solution is in place. Moving on to our PDS preferred initiatives. As of Q3, we have achieved our goal of 38 PDS preferred payers. We signed one additional preferred payer agreement in the quarter and now expect to land closer to 40 agreements by the end of 2026. Aveanna's preferred payer strategy continues to gain momentum and allows us to invest in caregiver wages and recruitment efforts to accelerate hiring and staffing of nurses for our payer partners. Additionally, our Q3 preferred payer agreements now account for 65% of our total PDS MCO volumes, up from 57% at the end of 2025.
This positive momentum in preferred payer volumes continues to highlight the shift in our caregiver capacity and recruitment efforts towards our preferred payer partners. Moving to our preferred payer progress in Home Health. Our goal for 2026 was to maintain our episodic mix above 75% while returning to a more normalized growth rate. I am pleased to report in Q3, our episodic mix was 80% and our total episodic volume growth was 24% compared with the prior year period. Our growth was fueled by an impressive 19.6% episodic admission growth compared with the prior year period. Furthermore, we signed two additional episodic agreements in Q3 for a total of 52 agreements year to date. While we have exceeded our preferred payer and our organic growth goals in Home Health, we continue to lean into our payer partners.
Our dedicated focus on aligning our Home Health caregiver capacity with those payers willing to reimburse us on an episodic basis has led to double-digit year-over-year growth in Home Health admissions and episodes, as well as improvement in our clinical and financial outcomes. Lastly, we are pleased with CMS's final home health rule published on November 4th, as well as the final hospice rule published on August 6th. The 2027 final home health rate shows positive movement by CMS, aligned with a strong collaboration from the National Alliance for Care at Home. While there is still work to be done addressing the temporary adjustment and its impact on the annual home health rate, we have come a long way as an industry.
We believe the stability of the Home Health and Hospice rate structure are important as we continue to meet the increasing demand for America's aging population cared for in the comfort of their home. Finally, as we have achieved our desired preferred payer model in both Private Duty Services and Home Health and Hospice, we are executing a similar strategy in our Medical Solutions business. As of Q3, we have a total of 22 preferred payer agreements, having added two in the quarter. Our gross margins have stabilized in our desired range as we align our clinical capacity with those payers that value our services and pay us in a timely fashion. I am very pleased with our Q3 volume growth of approximately 98,000 unique patients served, or positive 7.7% over the prior year period.
As we think about Medical Solutions revenue growth, I expect us to remain in the high single digits consistent with our long-term growth projections. We are encouraged by our rate increases, preferred payer agreements, and subsequent growth in our business. Our company has demonstrated a stable return to organic growth as we achieve our rate goals previously discussed. Home and community-based care will continue to grow, and Aveanna is a comprehensive platform with a diverse payer base, providing a cost-effective, high-quality alternative to higher-cost care settings. Now, turning to our acquisition of Family First Homecare, which we closed in June of this year. We are progressing nicely with the integration and have completed essentially all the back-office functions in Q3. Our leadership teams continue to focus on exceptional clinical care and supporting our branches as we navigate the necessary in-market and EMR integrations.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
12 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
